TGFB1 and neoplasm: Regarding NSCLC, Marwitz S. et al. (2020) recently demonstrated that pirfenidone reduces tumor cell viability, proliferation and migration by inducing a G0/G1 cell cycle arrest and downregulating the TGF-β/SMAD signaling pathway [30].